These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 25810107)
1. Mutant p53 expression in fallopian tube epithelium drives cell migration. Quartuccio SM; Karthikeyan S; Eddie SL; Lantvit DD; Ó hAinmhire E; Modi DA; Wei JJ; Burdette JE Int J Cancer; 2015 Oct; 137(7):1528-38. PubMed ID: 25810107 [TBL] [Abstract][Full Text] [Related]
2. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma]. Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967 [No Abstract] [Full Text] [Related]
3. A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development. Sherman-Baust CA; Kuhn E; Valle BL; Shih IeM; Kurman RJ; Wang TL; Amano T; Ko MS; Miyoshi I; Araki Y; Lehrmann E; Zhang Y; Becker KG; Morin PJ J Pathol; 2014 Jul; 233(3):228-37. PubMed ID: 24652535 [TBL] [Abstract][Full Text] [Related]
4. PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer. Modi DA; Tagare RD; Karthikeyan S; Russo A; Dean M; Davis DA; Lantvit DD; Burdette JE Oncogene; 2017 May; 36(21):3015-3024. PubMed ID: 27991925 [TBL] [Abstract][Full Text] [Related]
5. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors]. Wen J; Shi JL; Shen DH; Chen YX; Song QJ Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451 [TBL] [Abstract][Full Text] [Related]
7. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium. Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161 [TBL] [Abstract][Full Text] [Related]
8. Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis. George SH; Milea A; Sowamber R; Chehade R; Tone A; Shaw PA Oncogene; 2016 Jan; 35(1):59-68. PubMed ID: 25798842 [TBL] [Abstract][Full Text] [Related]
9. Tumorigenesis and peritoneal colonization from fallopian tube epithelium. Eddie SL; Quartuccio SM; Ó hAinmhir E; Moyle-Heyrman G; Lantvit DD; Wei JJ; Vanderhyden BC; Burdette JE Oncotarget; 2015 Aug; 6(24):20500-12. PubMed ID: 25971410 [TBL] [Abstract][Full Text] [Related]
10. Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface. Karthikeyan S; Lantvit DD; Chae DH; Burdette JE Oncotarget; 2016 Oct; 7(43):69871-69882. PubMed ID: 27563818 [TBL] [Abstract][Full Text] [Related]
11. PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma. Ghannam-Shahbari D; Jacob E; Kakun RR; Wasserman T; Korsensky L; Sternfeld O; Kagan J; Bublik DR; Aviel-Ronen S; Levanon K; Sabo E; Larisch S; Oren M; Hershkovitz D; Perets R Oncogene; 2018 Apr; 37(17):2213-2224. PubMed ID: 29379162 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor (IGF) and hepatocyte growth factor (HGF) in follicular fluid cooperatively promote the oncogenesis of high-grade serous carcinoma from fallopian tube epithelial cells: Dissection of the molecular effects. Chu TY; Khine AA; Wu NY; Chen PC; Chu SC; Lee MH; Huang HS Mol Carcinog; 2023 Sep; 62(9):1417-1427. PubMed ID: 37265438 [TBL] [Abstract][Full Text] [Related]
13. Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma. Chui MH; Vang R; Wang TL; Shih IM; VandenBussche CJ Cancer Cytopathol; 2019 Mar; 127(3):192-201. PubMed ID: 30861338 [TBL] [Abstract][Full Text] [Related]
14. Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma. Jazaeri AA; Bryant JL; Park H; Li H; Dahiya N; Stoler MH; Ferriss JS; Dutta A Neoplasia; 2011 Oct; 13(10):899-911. PubMed ID: 22028616 [TBL] [Abstract][Full Text] [Related]
15. IS "OVARIAN" CANCER A MISNOMER? EXPLORING OVARIAN CANCER ORIGINS IN THE MOUSE. Cho KR Trans Am Clin Climatol Assoc; 2018; 129():40-47. PubMed ID: 30166697 [TBL] [Abstract][Full Text] [Related]
16. The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube. Xian W; Miron A; Roh M; Semmel DR; Yassin Y; Garber J; Oliva E; Goodman A; Mehra K; Berkowitz RS; Crum CP; Quade BJ J Pathol; 2010 Jan; 220(1):17-23. PubMed ID: 19834951 [TBL] [Abstract][Full Text] [Related]
17. Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube? Klotz DM; Wimberger P Arch Gynecol Obstet; 2017 Dec; 296(6):1055-1062. PubMed ID: 28940023 [TBL] [Abstract][Full Text] [Related]
18. Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo. Pereira M; Glogova A; Haagsma J; Stewart J; Shepherd TG; Petrik J J Ovarian Res; 2023 Nov; 16(1):218. PubMed ID: 37986175 [TBL] [Abstract][Full Text] [Related]
19. Detection of serous precursor lesions in resected fallopian tubes from patients with benign diseases and a relatively low risk for ovarian cancer. Nishida N; Murakami F; Higaki K Pathol Int; 2016 Jun; 66(6):337-42. PubMed ID: 27250113 [TBL] [Abstract][Full Text] [Related]
20. Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers. Karst AM; Jones PM; Vena N; Ligon AH; Liu JF; Hirsch MS; Etemadmoghadam D; Bowtell DD; Drapkin R Cancer Res; 2014 Feb; 74(4):1141-52. PubMed ID: 24366882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]